Author:
Pützer Brigitte M.,Schmidt A.
Reference179 articles.
1. Alemany R, Balague C, Curiel DT (2000) Replicative adenoviruses for cancer therapy. Nat Biotechnol 18:723–727.
2. Alemany R, Curiel DT (2001) CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 8:1347–1353.
3. Ali M, Lemoine NR, Ring CJ (1994) The use of DNA viruses as vectors for gene therapy. Gene Ther 1:367–384.
4. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8:121–127.
5. Arap W, Pasqualini R (2001) The human vascular mapping project. Selection and utilization of molecules for tumor endothelial targeting. Haemostasis 31 Suppl 1:30–31.